Role of endothelin-1 in a cirrhotic rat model with endotoxin induced acute renal failure

Hepatology Research

Volumn 24, Issue 2, 2002, Pages 114-124

  Özdogan, Osman ^a   Goren M Zafer ^a   Ratip, Siret ^a   Giral, Adnan ^a   Moini, Haidi ^a   Enç, Firuze ^a   Birsel, Serpil ^a   Berkman, Kemal ^a   Tözün, Nurdan ^a  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Bosentan; Cirrhosis; Endothelin 1; Hepatorenal syndrome; Nitric oxide

Indexed keywords

BOSENTAN; CARBON TETRACHLORIDE; CREATININE; DRINKING WATER; ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST; ENDOTOXIN; NITRIC OXIDE; NITROUS OXIDE; PHENOBARBITAL; SODIUM ION;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG EFFECT; KIDNEY FUNCTION; KIDNEY FUNCTION TEST; LIVER CIRRHOSIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SODIUM EXCRETION; URINALYSIS; URINE VOLUME;

EID: 0036788931     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6346(02)00082-7     Document Type: Article

References (46)

1. Gines A, Escorsell A, Gines P, et al. Incidence, predictive factors and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology 1993;105:229-36.
2. Gines P, Arroyo V. Hepatorenal syndrome. J Am Soc Nephrol 1999;10:1833-99.
3. Moore K, Wendon J, Frazer M, Karaný J, Williams R, Badr K. Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. New Engl J Med 1992;327:1774-8.
4. Uchihara M, Izumi N, Sato C, Maruma F. Clinical significance of elevated plasma endothelin concentration in patients with cirrhosis. Hepatology 1992;16:95-9.
5. Asbert M, Gines A, Gines P, Jimenez W, Claria J, Salo J, Arroyo V, Rivera F, Rodes J. Circulating levels of endothelin in cirrhosis. Gastroenterology 1993;104:1485-91.
6. Gerbes AL, Moller S, Gulberg V, Henriksen H. Endothelin-1 and -3 plasma concentrations in patients with cirrhosis. Role of splanchic and renal passage and liver function. Hepatology 1995;21:735-9.
7. Tsai Y, Lin H, Yang M, Lee F, Hou CM, Chen LS, Lee SD. Plasma endothelin levels in patients with cirrhosis and their relationship to the severity of cirrhosis and renal function. J Hepatol 1995;23:681-8.
8. Salo J, Francitora A, Follo A, Navasa M, Gines A, Jimenez W, Gines P, Arroyo V, Rivera F, Rodes J. Increased plasma endothelin in cirrhosis. Relationship with systemic endotoxemia and response to changes in effective blood volume. J Hepatol 1995;22:389-98.
9. Bernardi M, Gülberg V, Colantoni A, Trevasani F, Gasbarrani A, Gerbes LA. Plasma endothelin-1 and -3 in cirrhosis: relationship with systemic hemodynamics, renal function and neurohumoral systems. J Hepatol 1996;24:161-8.
10. Masumoto H, Uemasu J, Kitano M, Kawasaki H. Clinical significance of plasma, endothelin-1 in patients with chronic liver disease. Dig Dis Sci 1994;39:2665-70.
11. Pinzani M, Milani S, Franco R, Grappone C, Caliguri A, Gentillini A, Tosti-Guera C, Maggi M, Failli P, Ruocco C, Gentillini P. Endothelin-1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells. Gastroenterology 1996;110:534-48.
12. 4 treated rats. Acta Hepatol Jpn 1993;34:328-34.
13. Anggard EE, Botting RM, Vane JR. Endothelins. Blood Vessels 1990;27:269-81.
14. Levin ER. Endothelins. New Engl J Med 1995;333:356-63.
15. Arroyo V, Jimenez W. Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem. J Hepatol (Suppl) 2000;32:157-70.
16. Lumbsden AB, Henderson JM, Kutner MH. Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis. Hepatology 1986;8:232-6.
17. Bigatello LM, Broitman SA, Fattori L, Di Paoli M, Pontello BSM, Bevilacqua G, Nespoli A. Endotoxemia, encephalopathy and mortality in cirrhotic patients. Am J Gastroenterol 1987;82:11-5.
18. Fukuki H, Brauner B, Bode JC. Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with improved chromogenic assay. J Hepatol 1991;12:162-9.
19. Wilkinson SP, Moodie H, Stamakis JD. Endotoxemia and renal failure in cirrhosis and obstructive jaundice. Br Med J 1976;2:1415-8.
20. Ninomiya H, Uchida Y, Ishii Y, Nomura A, Kameyama M, Sotema M, Endo T, Hasegewa S. Endotoxin stimulates endothelin release from cultured epithelial cells of guinea-pig trachea. Eur J Pharmacol 1991;203(2):299-302.
21. Sugiura M, Inagami T, Kon V. Endotoxin stimulates endothelin release in vivo and in vitro as determined by radioimmunoassay. Biochem Biophys Res Commun 1989;161:1220-7.
22. Morise Z, Ueda M, Aiura K, Endo M, Kitajima M. Pathophysiologic role of endothelin-1 in renal function in rats with endotoxic shock. Surgery 1994;115:199-204.
23. Curzen NP, Kaddoura S, Griffiths MJ, Evans TW. Endothelin-1 in rat endotoxemia: mRNA expression and vasoreactivity in pulmonary and systemic circulations. Am J Physiol 1997;272(5 Pt 2):H353-60.
24. Martin PY, Gines P, Schrier RW. Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis. New Engl J Med 1998;339:533-41.
25. Hecker M, Mulch A, Bassenge E, et al. Vasoconstriction and increased flow: two principle mechanisms of shear stress-dependent endothelial autacoid release. Am J Physiol 1993;265:H828-33.
26. Guarner C, Sorino G, Tomas A, et al. Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. Hepatology 1993;18:1139-43.
27. Stark ME, Szursewski JH. Role of nitric oxide in gastrointestinal and hepatic function and disease. Gastroenterology 1992;103:1928-49.
28. 4 an adequate model of human cirrhosis. Hepatology 1983;3:112-20.
29. Aristo F, Riggio O, Cantafora A, Colucci S, Gaudio E, Machell C. Carbon tetrachloride induced experimental cirrhosis in the rat. A reappraisal of the model. Eur Surg Res 1989;21:280-6.
30. Green LC, Wagner DA, Glogowski J, Skipper PL. Analysis of nitrate, nitrite and (15N) nitrate in biological fluids, Ann. Biochem. 1982;131-138.
31. Vallance P, Moncada S. Hyperdynamic circulation in cirrhosis: a role for nitric oxide. Lancet 1991;337:776-8.
32. Clozel M, Breu V, Gray GA, Kalina B, Löffler BM, Burri K, Cassal JM, Hýrth G, Müller M, Neidhart W, Ramuz H. Pharmacological characterisation of bosentan, a new potent orally active non-peptide endothelin receptor antagonist. J Pharmacol Exp Ther 1994;270:228-35.
33. Reichen J, Gerbes AL, Steiner MJ, Sagesser H, Clozel M. The effect of endothelin and its antagonist bosentan on hemodynamics and microvascular exchange in cirrhotic rat liver. J Hepatol 1998;28:1020-30.
34. Gurbanov K, Rubinstein I, Hoffman A, et al. Bosentan improves renal regional blood flow in rats with experimental congestive heart failure. Eur J Pharmacol 1996;310:193-6.
35. Sogni P, Moreau R, Gomola A, Gadano A, Cailmail S, Calmus Y, Clozel M, Lebrec D. Beneficial hemodynamic effects of bosentan, a mixed ETA and ETB receptor antagonist, in portal hypertensive rats. Hepatology 1998;28(3):655-60.
36. Herbert KJ, Hickey MJ, Lepore DA, et al. Effects of endothelin receptor antagonist bosentan on ischemia/reperfusion injury in rat skeletal muscle. Eur J Pharmcol 2001;424(1):59-67.
37. Prevot A, Semama DS, Tendron A, et al. Endothelin, angiotensin II and adenosine in acute cyclosporine A nephrotoxicity. Pediatr Nephrol 2000;14(10-11):927-34.
38. Fevang J, Ovrebo K, Myking O, Grong K, Svanes K. Role of endothelin in the circulatory changes associated with small bowel strangulation obstruction in pigs: effects of the endothelin receptor antagonist bosentan. J Surg Res 2001;96(2):224-32.
39. Pearl JM, Nelson DP, Wagner CJ, Lombardi JP, Duffy JY. Endothelin receptor blokade reduces ventricular dysfunction and injury after reoxygenation. Ann Thorac Surg 2001;72(2):565-70.
40. Heyman SN, Darmon D, Goldfarb M, et al. Endotoxin-induced renal failure. I. A role for altered renal microcirculation. Exp Nephrol 2000;8(4-5):266-74.
41. Roux S, Breu V, Ertel SI, Clozel M. Endothelin antagonism with bosentan: a review of potential applications. J Mol Med 1999;77(4):364-76.
42. Saraç AM, Özdemir A, Moini H, Birsel S, Scapa E. Role of endothelin-1 in obstructive jaundice. Dig Dis Sci 1999;44:356-63.
43. Buyukgebiz O, Aktan AO, Yegen C, et al. BQ 123, a specific endothelin A receptor antagonist prevents ischemia-reperfusion injury in kidney transplantation. Transplant Int 1996;9(3):201-7.
44. Pannen BH, Bauer M, Zhang JX, Robotham JL, Clemens MG. A time-dependent balance between endothelins and nitric oxide regulating portal resistance after endotoxin. Am J Physiol 1996;271:H1953-61.
45. Kohan ED. Endothelins: renal tubular synthesis and actions. Clin Exp Pharmacol Physiol 1996;23:337-44.
46. Hocher B, Zart R, Diekman F, Gross P, Distler A, Bauer C. Renal endothelin systems in rats with liver cirrhosis. J Cardivasc Pharmacol 1995;26(Suppl.3):S434-5.